Press release
NHU Awarded First Prize in Shandong Science and Technology Progress Awards
On June 27, at the Shandong Provincial Science and Technology Conference held in Jinan, the project titled "Key Technology Development and Industrialization of Green Synthesis of High-Quality D,L-Methionine", independently developed by Shandong NHU Amino Acid Co., Ltd., a subsidiary of NHU, was awarded First Prize in the Shandong Provincial Science and Technology Progress Awards. This marks the third time NHU has received a provincial-level first prize in S&T progress awards, reaffirming our strong capabilities and achievements in technological innovation.D,L-Methionine is an essential additive in animal feed with vast market demand. In response to this, NHU has made significant breakthroughs in several critical "bottleneck" technologies, focusing on green processes, continuous production, automated control, and premium product quality. We have successfully developed a proprietary, high-quality D,L-methionine production package technology with independent intellectual property rights.
A production line for high-quality D,L-methionine has already been established. Core indicators including product quality, material and energy efficiency, and emissions have reached industry-leading levels. This achievement not only ensures the secure supply of high-quality D,L-methionine in China, but also contributes significantly to the healthy development of the downstream trillion-yuan livestock industry, generating notable economic and social benefits.
Guided by the R&D philosophy of "demand-driven internal-external synergy", NHU continues to rely on its "chemical+" and "biological+" technology platforms and pursues functional chemical innovation with the spirit of "forging a sword in ten years". Looking ahead, NHU will take this honor as a new starting point, uphold our innovation-driven approach, and deepen research in future-proof, industrialization-oriented, and applied technologies in both chemical synthesis and biotechnology. With an open mindset and a commitment to internal-external synergy, NHU remains dedicated to advancing the high-quality development of the chemical industry and creating more sustainable value along the journey.
Media Contact
Company Name: Lingrong Culture
Contact Person: Wang Yurong
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nhu-awarded-first-prize-in-shandong-science-and-technology-progress-awards]
Phone: 2134007851
Address:3185 Wilshire blvd
City: Los Angeles
State: CA
Country: United States
Website: http://www.lingrongculture.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NHU Awarded First Prize in Shandong Science and Technology Progress Awards here
News-ID: 4103455 • Views: …
More Releases from ABNewswire

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…

Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…

Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…

Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Retinal Vein Occlusion pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
More Releases for NHU
NHU 2024 Annual Commendation: Honoring Excellence, Inspiring Growth
The timeline is ever-evolving, with each new chapter unfolding continuously. In 2024, NHU cultivated hope through hard work and lighted the way to the future with perseverance. Every challenge leads to a new height, and each success marks a fresh milestone. On January 20th, representatives of management and employees from subsidiaries nationwide gathered in Xinchang to reflect on the past, celebrate achievements, align their thoughts, set clear goals, and unite…
NHU Attended the 10th ICGC, Seeking for Sustainable Development
Image: https://www.abnewswire.com/uploads/37d969c6fe3f637bf8f5c55068f3025e.jpg
From October 19th to 21st, the 10th IUPAC International Conference on Green Chemistry (ICGC), co-hosted by the Chinese Chemical Society, the Institute of Chemistry of the Chinese Academy of Sciences, and the Green Chemistry for Sustainable Development Committee of the International Union of Pure and Applied Chemistry (IUPAC) was successfully held at the Beijing International Convention Center with the theme of "Green Chemistry for a Sustainable Future".
Image: https://www.abnewswire.com/uploads/32e6b60261316244dbda762d2e8df20b.jpg
As one…
NHU Made Its Debut at CPHI Korea
From August 27th to 29th, CPHI Korea took place at the COEX Convention Center in Seoul, Korea. NHU made its debut at this international event (Booth No. Q11), garnering significant attention and acclaim from both domestic and international exhibitors and buyers. NHU showcased its core pharmaceutical raw materials, including pharm-grade Vitamin C, Vitamin E, Vitamin B6, Moxifloxacin Hydrochloride, Ibuprofen, as well as various nutritional and health products like food-grade Vitamin…
NHU Organized The 2024 NHU Human Nutrition High Quality Development Forum
To advance the realm of human nutrition products and address the increasing market needs, NHU organized the 2024 NHU Human Nutrition High Quality Development Forum on May 30th in Xinchang. Over 130 experts, scholars, and key customers convened at the event to discuss the innovative technologies and sustainable development within the nutrition and health sector.
Image: https://www.abnewswire.com/uploads/66e639ec143cdb1e8b9db8dbf405b2a1.png
Staying True to Original Aspirations, Embracing Mission with Resolve
During his opening speech, Mr. Hu Bofan,…
Global Coenzyme Q10 Market 2018 - Haotian, ZMC, NHU
Apex Market Research, recently published a detailed market research study focused on the "Coenzyme Q10 Market" across the global, regional and country level. The report provides 360° analysis of "Coenzyme Q10 Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Coenzyme Q10 industry, and estimates the future trend of Coenzyme Q10 market…
Vitamin D Market 2017- NHU, DSM, BASF, Zhejiang Medicine
Marketreports.biz, recently published a detailed market research study focused on the "Vitamin D Market" across the global, regional and country level. The report provides 360° analysis of "Vitamin D Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vitamin D industry, and estimates the future trend of Vitamin D market on…